Matches in SemOpenAlex for { <https://semopenalex.org/work/W2114791874> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W2114791874 endingPage "828" @default.
- W2114791874 startingPage "825" @default.
- W2114791874 abstract "To inform clinicians of the potential for severe and persistent facial hyperpigmentation with the long-term use of imipramine.A 65-year-old white male veteran with a history of paranoid schizophrenia was referred to the psychiatry service by a dentist who thought that the patient was both cyanotic and psychotic. The history and biopsy results indicated the possibility of imipramine-associated hyperpigmentation, only the second reported case in a male patient. The presentation was complex, with a history of neuroleptic exposure and multiple signs of parkinsonism. A brain single photon-emission computed tomography scan demonstrated frontal lobe hypermetabolism and bilateral caudate hypermetabolism, which normalized 14 months later. Despite discontinuation of imipramine, the patient continued to appear cyanotic, leading to worsening social isolation. He became known as the man with the purple face. On his rare ventures outside the home, he was embarrassed by sporadic calls to 911 by persons fearing he was ill.Although facial hyperpigmentation secondary to the use of phenothiazines has been reported frequently, it is much less common with imipramine, and is very rare in males. Failure to recognize this adverse reaction led to continuing treatment with imipramine and to an apparently irreversible condition. The brain imaging findings have no link with the hyperpigmenting process, but raise questions about neuroleptic-induced metabolic changes in the brain.Clinicians need to be aware of rare adverse reactions such as hyperpigmentation, and be prepared to take appropriate and early action to prevent such reactions from becoming irreversible." @default.
- W2114791874 created "2016-06-24" @default.
- W2114791874 creator A5055081147 @default.
- W2114791874 creator A5082644329 @default.
- W2114791874 date "2003-06-01" @default.
- W2114791874 modified "2023-09-26" @default.
- W2114791874 title "Imipramine-Associated Hyperpigmentation" @default.
- W2114791874 cites W2022535309 @default.
- W2114791874 cites W2030778698 @default.
- W2114791874 cites W2067978628 @default.
- W2114791874 cites W2069064674 @default.
- W2114791874 cites W2087796244 @default.
- W2114791874 cites W2094901621 @default.
- W2114791874 cites W2121899599 @default.
- W2114791874 cites W2400985448 @default.
- W2114791874 cites W2418505212 @default.
- W2114791874 cites W4213099923 @default.
- W2114791874 doi "https://doi.org/10.1345/aph.1c431" @default.
- W2114791874 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12773071" @default.
- W2114791874 hasPublicationYear "2003" @default.
- W2114791874 type Work @default.
- W2114791874 sameAs 2114791874 @default.
- W2114791874 citedByCount "8" @default.
- W2114791874 countsByYear W21147918742021 @default.
- W2114791874 crossrefType "journal-article" @default.
- W2114791874 hasAuthorship W2114791874A5055081147 @default.
- W2114791874 hasAuthorship W2114791874A5082644329 @default.
- W2114791874 hasConcept C118552586 @default.
- W2114791874 hasConcept C126322002 @default.
- W2114791874 hasConcept C142724271 @default.
- W2114791874 hasConcept C16005928 @default.
- W2114791874 hasConcept C187212893 @default.
- W2114791874 hasConcept C204787440 @default.
- W2114791874 hasConcept C2776728111 @default.
- W2114791874 hasConcept C2777464067 @default.
- W2114791874 hasConcept C2778715236 @default.
- W2114791874 hasConcept C2779145073 @default.
- W2114791874 hasConcept C2779406339 @default.
- W2114791874 hasConcept C71924100 @default.
- W2114791874 hasConceptScore W2114791874C118552586 @default.
- W2114791874 hasConceptScore W2114791874C126322002 @default.
- W2114791874 hasConceptScore W2114791874C142724271 @default.
- W2114791874 hasConceptScore W2114791874C16005928 @default.
- W2114791874 hasConceptScore W2114791874C187212893 @default.
- W2114791874 hasConceptScore W2114791874C204787440 @default.
- W2114791874 hasConceptScore W2114791874C2776728111 @default.
- W2114791874 hasConceptScore W2114791874C2777464067 @default.
- W2114791874 hasConceptScore W2114791874C2778715236 @default.
- W2114791874 hasConceptScore W2114791874C2779145073 @default.
- W2114791874 hasConceptScore W2114791874C2779406339 @default.
- W2114791874 hasConceptScore W2114791874C71924100 @default.
- W2114791874 hasIssue "6" @default.
- W2114791874 hasLocation W21147918741 @default.
- W2114791874 hasLocation W21147918742 @default.
- W2114791874 hasOpenAccess W2114791874 @default.
- W2114791874 hasPrimaryLocation W21147918741 @default.
- W2114791874 hasRelatedWork W1504684939 @default.
- W2114791874 hasRelatedWork W2033177706 @default.
- W2114791874 hasRelatedWork W2054421556 @default.
- W2114791874 hasRelatedWork W2072296607 @default.
- W2114791874 hasRelatedWork W2114791874 @default.
- W2114791874 hasRelatedWork W2142813319 @default.
- W2114791874 hasRelatedWork W2413362288 @default.
- W2114791874 hasRelatedWork W2418051606 @default.
- W2114791874 hasRelatedWork W2466043692 @default.
- W2114791874 hasRelatedWork W4220859615 @default.
- W2114791874 hasVolume "37" @default.
- W2114791874 isParatext "false" @default.
- W2114791874 isRetracted "false" @default.
- W2114791874 magId "2114791874" @default.
- W2114791874 workType "article" @default.